PPAR delta, agonists

Accession Number

DBCAT001674

Description

Not Available

Drugs

Drug	Drug Description
Elafibranor	Investigated for use/treatment in atherosclerosis and diabetes mellitus type 2.
Seladelpar	Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.

Drugs & Drug Targets

Drug	Target	Type
Elafibranor	Peroxisome proliferator-activated receptor alpha	target
Elafibranor	Peroxisome proliferator-activated receptor delta	target
Elafibranor	Peroxisome proliferator-activated receptor gamma	target